Skip to main content
Livermore
Livermore
ZHEN

Invesco Ltd.

SEC CIK
0000914208
Latest filing
Aug 14, 2026

MCRB holding history

Seres Therapeutics, Inc. in every 13F filed by Invesco Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MCRB overviewAll 13F holders of MCRBFull Q2 2026 holdings

Shares (Q2 2026)
12,974
Value
$102.4K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of MCRB by Invesco Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,974$102.4K<0.1%−1,573−10.8%ReducedHolders
Q1 202614,547$129.0K<0.1%+187+1.3%AddedHolders
Q4 202514,360$213.7K<0.1%+3,918+37.5%AddedHolders
Q3 202510,442$200.9K<0.1%+10,442NewHolders
Q2 20250$00.0%−6,829−100.0%Sold outConverted for a 1-for-20 splitHolders
Q1 2025136,572$95.6K<0.1%+89,995+193.2%AddedHolders
Q4 202446,577$38.7K<0.1%−8,641−15.6%ReducedHolders
Q3 202455,218$52.2K<0.1%+15,959+40.7%AddedHolders
Q2 202439,259$28.4K<0.1%−23,707−37.7%ReducedHolders
Q1 202462,966$48.7K<0.1%+5,966+10.5%AddedHolders
Q4 202357,000$79.8K<0.1%+13,642+31.5%AddedHolders
Q3 202343,358$103.2K<0.1%+2,262+5.5%AddedHolders
Q2 202341,096$196.9K<0.1%+6,069+17.3%AddedHolders
Q1 202335,027$198.6K<0.1%+833+2.4%AddedHolders
Q4 202234,194$191.5K<0.1%−535,403−94.0%ReducedHolders
Q3 2022569,597$3.66M<0.1%+538,849+1,752.5%AddedHolders
Q2 202230,748$106.0K<0.1%−978−3.1%ReducedHolders
Q1 202231,726$225.0K<0.1%−30.0%ReducedHolders
Q4 202131,729$264.0K<0.1%−8,520−21.2%ReducedHolders
Q3 202140,249$281.0K<0.1%+6,604+19.6%AddedHolders
Q2 202133,645$802.0K<0.1%+19,087+131.1%AddedHolders
Q1 202114,558$300.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.